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Abstract
The transport of platelets in blood is commonly assumed to obey an advection-diffusion equation. Here we propose a
disruptive view, by showing that the random part of their velocity is governed by a fat-tailed probability distribution,
usually referred to as a Le´vy flight. Although for small spatio-temporal scales, it is hard to distinguish it from
the generally accepted “red blood cell enhanced” Brownian motion, for larger systems this effect is dramatic as
the standard approach may underestimate the flux of platelets by several orders of magnitude, compromising in
particular the validity of current platelet function tests.
Keywords: platelets, anomalous transport, fat-tailed distributions, power law behaviour, cellular blood flow simu-
lations, random walks, stochastic models
1 Introduction
Platelets (PLTs) are the second most numerous cell in blood, after red blood cells (RBCs), with concentration of
150-450×109/l. Their size, shape and material allow them to be optimally placed as close as possible to the vessel
wall, a physical requirement for the constant inspection of the integrity of the vasculature. Platelets are polyvalent
entities and are involved in multiple physiological and pathophysiological processes such as haemostasis, thrombosis,
clot retraction, vessel constriction and repair, inflammation including promotion of atherosclerosis, host defence,
and even tumour growth/ metastasis [1]. Upon injury platelets respond rapidly (through activation, adhesion,
aggregation, release reactions, etc.), and form a haemostatic plug, occluding the damaged site and preventing blood
loss. Any disorder in these physiological processes results in impaired haemostasis, and inappropriate thrombus
formation. For example, arterial thrombi can develop within atherosclerotic lesions resulting in stroke and heart
attack, two of the major causes of morbidity and mortality in the western world [1]†.
Focal point of this analysis is the underlying mechanism of platelet transport, which has an impact on their
physiological/pathophysiological behaviour. Platelets move within blood due to the combined effect of the plasma
velocity and the collisions with RBCs. In particular, in a shear flow, PLTs experience a random motion in the
direction perpendicular to the flow. The accepted description of this process (the so-called Zydney-Colton theory
[2]) is that PLTs are subject to a diffusion process, whose diffusion coefficient is [3]
D = DPRP × (1−H) + 0.15× (d2RBC ×H/4)× γ˙ × (1−H)1.8 (1)
where DPRP is the diffusivity of PLTs in a platelet-rich plasma (without RBCs) and its values is typically DPRP =
O(10−13) m2/s. The quantity γ˙ is the shear rate, H is the hematocrit, and dRBC is the diameter of a RBC.
Equation (1) gives that D = O(10−11) m2/s, for the situation described in Chopard et al. [4], namely the diffusion
of PLTs in a shear flow with γ˙ = 100 s−1 and H = 0.35, as created by the so-called impact-R PLT analyser. This
device allows one to measure the amount of PLTs that deposit on a surface perpendicular to the flow. However,
∗Corresponding author: christos.kotsalos@unige.ch
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based on such experimental evidence, Chopard et al showed that if one assumes that the concentration ρ of PLTs
obeys the diffusion equation
∂ρ = D∇2ρ (2)
a value of D ≈ O(10−8) m2/s is needed to explain the number of platelets that is observed to deposit in impact-R
platelet analyser.
This result obviously raises the question of the validity of eq. (1) or the applicability of eq. (2). The Zydney-Colton
model results from accumulating experimental/theoretical data, and it has been extensively validated by numerous
numerical studies, in which RBCs and PLTs where resolved [5, 6, 7, 8, 9, 10, 11]. However, these studies concern
spatio-temporal scales much smaller than those characterising the impact-R device. The latter considers a layer of
blood of 820 µm of thickness, rotating in a cylinder of diameter 6.5 mm. The amount of platelets that disappeared
from the bulk due to their deposition on the bottom part of the cylinder was observed after 20 s. State of the art
numerical simulations consider much smaller systems, usually less than 100 µm in size, for less than 1 s of physical
time.
A possibility to explain this 1000-fold difference between the Zydney-Colton theory and the effective observed
diffusion is to postulate the presence of a drift term in addition to the diffusion process, as suggested in [12, 5, 13], as
a general mechanism for the case of transport of deformable suspensions. This drift-diffusion model, which includes
a “rheological potential” (Φ), has however an ill-considered/posed origin. Furthermore, due to the symmetry of
the problem it is hard to understand why such a symmetry breaking would appear in the case of the impact-R.
As a matter of fact, simulations of PLT transport in the impact-R, including an ad hoc drift term and a Zydney-
Colton diffusion, do not fit so well the in-vitro time evolution of PLTs deposition (data unpublished, B. Chopard
2018).
Our claim in the present paper is that it is possible to reconcile these contradictory results by assuming that PLTs
do not follow a Gaussian random walk (as is implied by the standard diffusion equation), but a random walk
with a fat-tailed distribution of velocities. We show here that a very careful analysis of fully resolved blood flow
simulations, in which deformable RBCs and platelets interact and move in a suspending fluid (the plasma) reveals
that collisions between RBCs and PLTs result in a power law probability distribution of PLT velocities,
P (v) ∼ v−1−α (3)
with α around 1.5. We also show that for small systems, the value of the PLT mean square displacement (MSD),
which is traditionally related to the diffusion coefficient, is compatible with the Zydney-Colton theory, explaining
why the normal diffusion hypothesis was little questioned in the literature. But as the system size increases, we
observed that the MSD increases, a behaviour incompatible with a Gaussian random walk.
It should be noted that, despite this wide consensus that Zydney-Colton theory applies, a few researchers have
superficially pointed out events that support our current result. Vahidkhah et al. [9, 14] observed highly anisotropic
RBC distribution and a “waterfall” phenomenon (cavities that act as express lanes for platelets) affecting PLT
movement (supported experimentally by Lee et al. [15]). Mehrabadi et al. [10] pointed out a possible anomalous
diffusion as PLTs get trapped in the cell free layer. Yeo et al. [16] (same approach as Gross et al. [17]) who talked
about anomalous diffusion of wall-bounded non-colloidal suspensions, observed exponential distributions for the
densely packed spherical particles (correspondence to RBCs).
It is critical to understand, why an underlying power law behaviour leads to enormous differences in transport
physics. In figure 1, we present five particles with the same average jump length (three of them exhibit power law
behaviour, and two of them follow a Gaussian distribution). All particles start from the same point and are left to
explore the space for a thousand iterations. The particles performing Le´vy flights exhibit jumps with probability
density function ∼ x−1−α and an average jump of size α/(α − 1) for α > 1 (see Pareto distribution [18]). The
ones performing Gaussian random walks exhibit jumps with a Gaussian probability density function (µ = 0, σ = 1)
and an average jump of size
√
2/pi. We make sure that the average jump (J¯) is the same for every particle by
multiplying the individual jumps with a normalisation constant equal to J¯ ∗ (α−1)/α for the power laws, and equal
to J¯ ∗√pi/2 for the Gaussian jumps. The particles that perform Le´vy flights explore the space in a completely
different way than the Gaussian ones. Reconsidering platelet transport, how fast platelets reach the vessel walls is
a very critical information, and inextricably associated to the underlying characteristics of the probability density
function.
This paper is organised as follows. In section 2 we describe our methodology and the numerical tools we have
developed to detect the non-Gaussian behaviour of PLT motion. We also explain how we can bridge the scales
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Figure 1: Five particles performing random walks (three of them exhibit power law behaviour with varying exponent,
and two of them follow a Gaussian distribution). The exploration of the space is largely dependent on the underlying
probability density function.
between the high fidelity blood flow simulations, which are extremely computationally demanding, and the PLTs
displacement in the impact-R device. Our results are then presented in section 3. They consist in a careful statistical
analysis of the random motion of the simulated PLTs, and a simulation of the platelet deposition process of the
impact-R, based on the inferred properties of the random walk. Finally, in section 4 we discuss some implications
of our disrupting theory of PLTs motion.
2 Methods
Our goal is to understand whether the discrepancy found in Chopard et al [4] between the Zydney-Colton diffu-
sion coefficient and the one accounting for the PLTs deposition pattern observed in the impact-R device can be
explained by an anomalous diffusion process, thus ruling out the possibility to use eq. (2). As discussed in the
previous section we made the hypothesis that PLTs may obey a fat-tailed distributed random walk instead of a
Gaussian one. Due to the great difficulty to measure directly the movement of platelets (individual trajectories) in
whole blood with an in-vitro approach, numerical simulations are considered. We refer these simulations as DNS
(Direct Numerical Simulations) as they provide a high fidelity description of blood, integrating RBCs and PLTs
as deformable suspensions in a flowing plasma. However, state of the art DNS blood solvers are still limited to
rather small spatio-temporal scales. For this reason we will have to perform a very careful statistical analysis of the
platelet trajectories to evidence their non Gaussian behaviour at the reachable scales.
2.1 High Fidelity Blood Flow Simulations
Here we consider the Palabos-npFEM DNS blood solver [19, 20]. It offers high accuracy, flexibility and high
scalability on the top fastest parallel supercomputers. This computational framework couples the lattice Boltzmann
solver Palabos [21]∗ for the simulation of blood plasma (fluid phase), a finite element solver for the resolution of the
deformable blood cells (solid phase), and an immersed boundary method for the coupling of the two phases. The
framework resolves blood cells like RBCs and PLTs individually (both trajectories and deformed state), including
their detailed non-linear viscoelastic behaviour and the complex interaction between them.
Collisions between blood particles, whether RBCs or PLTs, are implemented through a repulsive force acting as
a spring, when the surfaces delimiting two particles are getting too close to each other. In the current study, we
∗https://palabos.unige.ch
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employ the same parameters as reported in Kotsalos et al. [19, 20], where one can find a detailed description of
the numerical models. However, the intensity of the repulsive force is varied here to account for the extra repulsion
between RBCs and activated platelets whose negative charge is increased with respect to that of non-activated
platelets.
We consider simulations in a 3D box as illustrated in the inset of Figure 4. The y-axis is oriented vertically. Two
horizontal no-slip walls are positioned at locations y = 0 and y = L, with L ∈ {50 µm, 100 µm, 250 µm, 500 µm}.
A shear flow is produced in the z-direction by moving the upper wall at a proper velocity. The shear rates we
consider are γ˙ = 100s−1 and γ˙ = 400 s−1. Periodic boundary conditions are imposed along the x and z horizontal
axes. This setup is meant to approximate the impact-R geometry for which L = 820 µm and the x and z axes
span a window of size 1 mm × 1 mm, embedded in a cylinder of diameter 6.5 mm (see [4] for more details). The
hematocrit is H = 35% and the ratio RBCs/PLTs is around 20.
The simulations are run for a time interval [t0, t1], which typically lasts 1 s of physical time. This interval is resolved
at the scale 10−8 s, the time step of the npFEM-Palabos solver. The trajectories yi(t) along the y-axis of all PLTs
i are recorded, based on the position of their centre of mass. From theses trajectories, one has to determine the
probability distribution of PLTs velocities. To properly sample the time series yi(t) of positions, one has to extract
the characteristic platelet mean free time, ∆t, representing the average time between successive impacts/collisions.
This characteristic time is important, because an under-sampling could result in missing important collision events,
and thus misinterpreting the motion of platelets. On the other hand, a sampling at a too fine time scale will sample
statistically dependent velocities, before collisions could randomise the platelet movements.
Multiple researchers define the sampling interval as ∼ γ˙−1, but this formula has no robust explanation. Alter-
natively, we consider the trajectories yi as seen at different time scale ∆t, for several possible values of ∆t ∈
{0.01 ms, 0.1 ms, 1.0 ms, 10.0 ms}. We compute the area A formed graphically by the trajectory yi(t) at full DNS
resolution, namely
A =
∫ t1
t0
yi(t)dt
Then we compute the area formed by the trajectory at scale ∆t (i.e. yi(t) with t incremented by steps ∆t). These
two areas should be identical if the platelet did not experience a collision during time ∆t. The larger ∆t for which
this equality holds is chosen as the mean free time.
Figure 2 presents this method. The vertical axis shows the relative deviation between these two areas, averaged
over all PLTs. The inset shows the trajectory of one representative platelet at three different time scales. We
see that ∆t = 1 ms captures well the change in the trajectory due to collisions, while filtering out irrelevant
oscillations.
The set of independent platelet velocities is then obtained from the quantities (where we set t0 = 0 for simplic-
ity)
vi(k) =
yi((k + 1)∆t)− yi(k∆t)
∆t
(4)
for all platelets i.
A classical property characterising the movement of platelets is their mean square displacement (MSD), defined
as
MSD(t) =
〈
(yi(t)− yi(0))2
〉
(5)
where the average is over all platelets i. This relation can also be written as
MSD(t) =
〈
t/∆t∑
k=1
vi(k)
t/∆t∑
`=1
vi(`)
〉
(6)
Assuming that vi(k) and vi(`) are independent when k 6= `, and that 〈vi〉 = 0 due to the symmetry along the y axis
(fact confirmed numerically for the current simulation setup), we obtain
MSD(t) =
t/∆t∑
k=1
〈
v2i (k)
〉
=
t
∆t
〈vi〉 (7)
The second equality comes from the fact that in a steady state, the velocity distribution is expected to be independent
of time. Note however that this hypothesis is only valid in the bulk of the sample, where RBCs are found to have a
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constant density along the y-axis. This is no longer the case in the so-called cell-free layer, near the walls at y = 0
and y = L. For this reason, we separate the treatment of platelets according to their spatial location and determine
the velocity distribution for the PLTs in the homogeneous region, away from the walls.
Equation (7) shows that MSD(t) is expected to be proportional to t, but this is only the case if < v2i > is finite
and well defined. We will show below that this is not the case for platelets in a shear flow. Actually the subtle
part of this observation is that, for any numerical simulation, < v2i > is obviously finite as there is a finite number
of platelets in the system, for a finite number of time steps. But as the system size is increased, we observed
that 〈v2i 〉 also increases, indicating a divergence of the variance of the platelet velocities. The striking result is
however that for small systems, namely those that are accessible to DNS blood flow simulations [5, 9, 10], the
non-converged computed value of 〈v2i 〉 is compatible with the Zydney-Colton diffusion coefficient, thus supporting
a misinterpretation of a Gaussian random walk.
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Figure 2: Deviation from the DNS platelet trajectories as a function of the time scale at which these trajectories
are observed. The way the deviation is measured is illustrated in the inset, for three different sampling intervals.
The black circles in the main figure show the average deviation, computed over all platelet trajectories. The “error”
bars mark the minimum and maximum deviations. One observes that a sampling interval ∆t = 10.0 ms (dashed
line in the inset) misses many collision events, but that ∆t = 0.1 ms is a proper choice.
2.2 Statistical Analysis of Platelet Velocities
In this section we explain how we determined the properties of the probability distribution of PLT velocities sampled
from the high fidelity blood flow simulations described in section 2.1.
To avoid wall effects, we discard the velocities corresponding to PLTs that are less than one RBC diameter from
the walls. In order to prove that PLT velocities are not normally distributed but have a rather high probability
for extreme events, we devised a set of methods originating from analyses of fat-tailed distributions for discerning
and quantifying power law behaviour in empirical data (in-depth analysis by Clauset et al. [22]). A graphical
explanation is provided in the Supplementary Material.
Family of Distributions
The term “Thick Tails” is often used to describe distributions with much higher kurtosis than the Gaussian one, and
“Fat Tails” is reserved for both extreme thick tails or membership in the power law class. We avoid designations such
as “Heavy Tails” or “Long Tails” to keep ambiguity to a minimum [23]. In literature, “Heavy Tails” is commonly
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linked to distributions which do not have all their moments finite/defined. The term sub-exponential distributions
is used for the ones that decay more slowly than an exponential, i.e. they are not exponentially bounded (popular
distribution belonging to this class is the log-normal). To summarise, the degree of thick tailedness (ranking by
severity) is Thick Tailed ⊃ Sub-exponential ⊃ Power Law/Fat-Tailed (Paretian). Furthermore, the thick tailed and
sub-exponential families have all their moments finite. We are particularly interested in the power law class to
describe PLT transport, because these distributions do not have all their moments finite/defined. This happens
for power law distributions whose tail decays like ∼ x−α−1 with α ≤ 2 (infinite/undefined variance and moments
above). For α ≤ 1 the mean of the distribution is infinite/undefined, as well.
In statistics, we can never prove that a given distribution describes the investigated data, instead we can increase
our confidence for a family of distributions against others. In our case, since we hypothesise that platelet velocities
follow power law distributions with exponent α ≤ 2, we focus on finding evidences supporting this null hypothesis.
Commonly used distributions that exhibit power law behaviour (asymptotically) are the Pareto, Cauchy (half-
Cauchy, for positive only data), Le´vy, Dagum (or Burr Type III), Singh–Maddala (or Burr Type XII), Log-logistic
(or Fisk), inverted Weibull (or Fre´chet) (see Supplementary Material: Power Law Distributions) [18]. Our approach
is to check, for each DNS, the plausibility of these distributions, according to the fitting criteria presented below.
Also we want to extract the asymptotic power law exponent and check how many of the distributions exhibit
α ≤ 2.
The distributions whose plausibility lowers our confidence on power laws are the normal and exponential distri-
butions. Generally, if a power law is not a better fit than an exponential distribution, there is scarce ground for
considering the distribution to be thick-tailed at all, let alone a power law [24]. Regarding the sub-exponential
class, a careful investigation of the sample moments can help us decide whether to disregard them or not.
Distribution Fitting
In practice, few phenomena obey power laws for all values of x (where x denotes PLT velocities). More often the
power laws apply only for values greater than some minimum value, xmin. In such cases, we say that the tail of
the distribution follows a power law [22]. Thereby, for every distribution mentioned above (power law or not), we
find this lower bound and perform the fitting at the tail. Regarding the remaining part of the data (body), this
can be sufficiently described by the empirical distribution function (histogram - see Supplementary Material). Note
however that this procedure does not apply when fitting the data to a Gaussian. In this case, the fit is done across
the whole range of velocities.
Once this lower bound is known, every distribution is fitted on the tail using the Maximum Likelihood Estimate
(MLE) method, and its plausibility is checked using the Kolmogorov-Smirnov (KS) test for goodness-of-fit. Given the
symmetry of the studied phenomenon (for the current simulation setup), we use the absolute value of the velocities
(no discrimination between upward and downward motions of PLTs). Thus all the statistics are one-tailed. If the
p-value of the KS test is greater than the significance level (10% throughout the study for goodness-of-fit tests),
then the investigated distribution could be a plausible fit to the data.
In addition to this goodness-of-fit test, we employ the Log-likelihood ratio (LLR) test [22] comparing the fitted
distribution with every alternative distribution proposed above (see Family of Distributions). In that case, the
smaller the p-value of the LLR test, the more confident we can be on which distribution is a good fit of the data.
The significance level for the LLR test is set to 1%. Note that, to confirm or deny a distribution, a small p-value is
“good” for the LLR test (shows how trustworthy is the test’s result), while it is “bad” for the KS test (shows that
the distribution is a poor fit to the data). Thus, for the acceptance/plausibility of a distribution fitted on the tail,
there exist two criteria to meet, i.e. the KS and LLR tests.
The estimation of xmin is an optimisation process, and is based on minimising the distance between the inves-
tigated model and the empirical data [22]. The metric d, that quantifies this distance, is the widely used Kol-
mogorov–Smirnov statistic, which is simply the maximum distance between the Cumulative Distribution Function
(CDF) of the sampled DNS data (the empirical CDF, noted S), and the CDF P of the fitted model. Thus
d = max
x≥xmin
|S(x)− P (x)| (8)
Therefore, the selected xmin is the one that minimises this distance. Keep in mind that for every x tested, the
parameters of P are fitted using the MLE method, which requires large enough samples. Thus, the minimisation
process described above stops when the remaining tail has less than 100 velocities.
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Bridging the scale: a Random Walk description
As indicated previously, we want to show that the unexpectedly high transport of PLTs observed by Chopard et
al. [4] in the in-vitro impact-R device is compatible with the velocity probability distribution extracted from our
DNS blood simulation. A direct verification is not possible as the spatio-temporal scales corresponding to the
impact-R is still too hard to reach, even on the fastest supercomputers: a cubic millimetre of blood simulated for
20 seconds.
A solution to bridge this gap of scales is to disregard the detailed movement of RBCs at the level of the impact-R,
and only consider the dynamics of PLTs in terms of a random walk, using the velocity distribution obtained from
the statistical analysis of the fully resolved PLT trajectories in the DNS simulations. Therefore we will simulate
the PLTs deposition process taking place in the impact-R through a stochastic model implementing the determined
random motion of PLTs. The question is to check whether this mesoscopic transport process reproduces the number
of PLTs observed to deposit at the bottom surface of the impact-R, after 20 s of operation. More precisely, the
experimental data [4] show that about 3000 activated platelets per micro-litre of whole blood have disappeared
from the bulk within these first 20 s.
This method follows the approach of Chopard et al. [4], by replacing the 1D diffusion equations describing the bulk
of the impact-R device with actual random walks of point particles. The PLTs that cross the lower boundary are
considered as deposited. Therefore, for every DNS, we perform the statistical analysis and, for every candidate of the
PLTs velocity distribution, we simulate the corresponding stochastic model and record the number of deposited PLTs
it predicts after 20 s. For more details on generating data for the random walks, see Supplementary Material.
3 Results & Discussion
Our analysis builds upon the research by Chopard et al. [4]. In more details, in the in-vitro part of their study
the researchers used the impact-R platelet function analyser to study the evolution of PLT deposition (adhesion-
aggregation processes) on the substrate of the device. Impact-R is a cylindrical apparatus (820 µm height), whose
lower end is a fixed disc (deposition surface, 132.7 mm2), and its upper wall a rotating disc. Due to the rotating
upper wall, the blood is subject to a pure shear flow. The imposed constant shear rate was 100 s−1 (inside an
observation window of 1 × 1 mm2), the blood was extracted from seven healthy donors. The differential role of
activated and non-activated platelets was analysed, as well as the role of albumin in the deposition process. The
in-silico counterpart of their study consisted of 1D diffusion equations describing the movement of activated platelets
(AP) and non-activated platelets (NAP) in the bulk of the device, and of stochastic rules for PLT deposition on the
substrate. The study revealed that the Zydney-Colton [2] shear induced diffusion coefficient (D) was significantly
too small to explain the observed deposition rate.
The fully resolved 3D cellular blood flow simulations (DNS) provide a great amount of information, that simplified
mechanistic models or in-vivo/vitro experiments cannot provide. Numerically following individual particles and
resolving the complex interactions, helped us develop an alternative theory on how platelets are transported. We
tried to reproduce numerically the in-vitro experiments performed in Chopard et al. [4], to the extent possible,
given the high computational cost. To reduce the computational demand, we designed our numerical simulations in
channels with lateral dimensions of 50 µm, while resolving the wall-bounded direction at {50, 100, 250, 500} µm.
Consider that the in-vitro counterpart consists of 1000 µm in the lateral directions, and 820 µm in the wall-bounded
direction. Numerically, we generated a constant shear rate flow regime at 100 s−1, realised with the help of a moving
top wall and a fixed bottom wall. Periodic boundaries were applied in the flow and vorticity directions, and the
hematocrit was 35%, as in the experiments.
Regarding the platelet size and shape, we considered experiments with either activated or non-activated PLTs. The
NAP are simulated as nearly-rigid oblate ellipsoids with diameters {2.5, 3.6} µm, thicknesses {0.6, 1.1} µm, and
volumes {2.0, 7.0} fl, respectively. The AP are simulated as nearly-rigid spheres with diameters {3.0, 3.6, 4.0,
5.0} µm (covering the uncertainty from the complicated shape transformations), and volumes {12, 22, 30, 60} fl,
respectively. Upon PLT activation, negatively charged phospholipids are translocated from the inner membrane to
the external surface, leading to a more negatively charged PLT. This complex electrochemical behaviour is quantified
by the electrophoretic mobility of platelets [25, 26, 27]. Additionally to the change of the electrophoretic mobility,
there is a severe change in shape with the appearance of blebs and pseudopods, which increases the hydrodynamic
volume of AP. While we address the latter alteration through the spherical shape, the complex electrochemical
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behaviour is roughly resolved through an increase in the intensity of the collision potential between activated PLTs
and RBCs, i.e. increased repulsive forces ranging from 5 to 10 times compared to the ones of NAP.
As for the RBCs, the normal biconcave shape is used in the majority of the experiments, while in few of them we
introduced spherised RBCs emulating pathological conditions [28], e.g. diabetes, chronic obstructive pulmonary
disease.
We performed 64 simulations on Piz Daint, the flagship system of the Swiss National Supercomputing Centre, which
is the fastest supercomputer in Europe and the 6th worldwide∗∗. These simulations include for completeness, 5 case
studies in a tube of 50 µm diameter, 5 case studies at 20% hematocrit, and 6 case studies with constant shear rate
at 400 s−1. Forty-one simulations follow the “exact” same setup as the experiments of Chopard et al. [4], but all
64 present qualitatively the same platelet transport behaviour. Out of the 41 simulations, 22 deal with AP (12 of
them include repulsive forces), and the rest deal with NAP. The graphs and results presented below include these
41 simulations.
Anomalous Transport From the Velocity Distribution
A standard diffusive process is unaffected by the size of the system (at least away from the walls), i.e. the moments
(e.g. variance, kurtosis) of the PLT velocities converge as the sample size increases. Figure 3 presents the diffusion
coefficient D of PLTs (AP/NAP) when extracted from the mean squared displacement, for channels of varying
sizes. Traditionally, the diffusion coefficient is linked to the MSD, as DMSD = MSD(t)/(2t) for 1D systems, e.g.
along the wall-bounded direction. The black square points in Figure 3 indicate the value of DMSD as a function of
the system size, averaged over all simulations. The “error” bars denote the minimum/maximum coefficients among
the various DNS.
In Figure 3 we also evaluate the PLT diffusivity DGauss (empty squares) when a Gaussian distribution is (poorly)
fitted on the observed PLT velocities. The DGauss is computed from the standard deviation of the corresponding
normal distribution. As expected, the latter approach returns a diffusion coefficient that is not affected by the
system size (small variations are due to different parameters in the DNS). However, for the diffusivity emerging
from the MSD, there is a diverging behaviour as the sample sizes increase, a signature of a fat-tailed velocity distri-
bution. On top of this observation, we show in the inset of Figure 3 the mean excess kurtosis (fourth standardised
moment) of platelet velocities, which presents a diverging behaviour as well, and values that are way higher than
the corresponding null value of a normal distribution.
Alongside with observing the moments of the data, we performed a number of normality tests to check if a Gaussian
distribution is a plausible model for the data. We deployed the Shapiro-Wilk, D’Agostino’s K2 and Anderson-
Darling normality tests to check this hypothesis. As expected, every normality test consistently rejected this
hypothesis.
Summarising, the extremely high kurtosis ( 0), the failed normality tests, and the diverging moments of PLT
velocities are the first signs of fat-tailed distributions, and more specifically they indicate presence of power laws
with exponents less than 2, i.e. infinite/undefined variance (second central moment) and moments above. A striking
observation is that the resulting diffusion coefficients from our numerical experiments are not far from the Zydney-
Colton model [2] or other numerical studies [9, 5, 10], i.e. they are consistently two to three orders of magnitude
higher than the Brownian diffusivity O(10−13) m2/s. As well accepted, our simulations confirm the role of PLTs-
RBCs collisions to enhance PLTs transport, but a further analysis implies that the diffusive process is anomalous.
Possibly, the suggestion for extra drift terms or rheological potentials [12, 5, 13] comes from a misinterpretation of
this anomalous diffusive process.
Power Law Emergence
From the statistical analysis of the sampled DNS output, we tried to find evidences that PLT velocities follow fat-
tailed distributions, and more specifically power laws with exponent α ≤ 2. Out of the 41 numerical experiments
only 2 of them did not show evidence of power laws, i.e. no valid fitting of power laws on the data was obtained.
For the rest, the tails of PLT velocities can be described with distributions which asymptotically behave as power
laws (see Family of Distributions in section 2, and Supplementary Material).
∗∗https://www.top500.org
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Figure 3: PLT diffusion coefficient D (black squares) estimated from the means square displacement of PLTs,
computed from the DNS. The values of D are given as a function of the size L along the y axis obtained by an
average over all the simulations. The “error” bars denote the minimum/maximum coefficients among the various
DNS. The white square indicates the diffusion constant that would correspond to a Gaussian random walk by
forcing a normal distribution fit on the measured PLT velocities. The inset presents the mean excess kurtosis of
PLT velocities coming from the DNS, as a function of L. The “error” bars correspond to the min/max values of the
kurtosis. The diverging moments clearly indicate fat-tailed distributions with infinite/undefined moments (power
law behaviour with exponent α ≤ 2).
Table 1 shows, for the different platelet types (non-activated platelets NAP, activated platelets AP, activated
platelets with repulsive forces, AP-rep) the power law exponent α averaged over all the fitted and accepted power
laws with exponent ≤ 2. The min/max indicated in table 1 denote the minimum and maximum values of the
exponent from the fitting of the various distributions (Pareto, half-Cauchy, Le´vy, Dagum, Singh–Maddala, Log-
logistic, and inverted Weibull) for each PLT type.
It is interesting to observe that the shape and the electrophoretic properties of platelets are reflected on the exponent
of the power law. The lower the power law exponent, the higher the mobility through “extreme” tail events. The
exponents observed for AP-rep are consistently smaller. In the Supplementary Material, we provide a table that
summarises the majority of the performed experiments with key quantities per DNS for the completeness of the
study, e.g. one can find per DNS the power law exponents (considering all fitted distributions with exponent
α ≤ 2).
Table 1: Mean power law exponent for the different PLT types, averaged over the simulations and power law
distributions. The min/max denote the variation of the exponent across the simulations. The simulated average
number of deposited PLTs in the impact-R is also computed based on the corresponding exponent. The maximum
deposition corresponds to the lowest power law exponent (fatter tails). The mean deposited PLTs based on a (poor)
fitting of normal or exponential distributions heavily underestimate the deposition observed in Chopard et al. [4].
NAP AP - no rep AP - rep
Mean Power Law α (min/max) 1.56 (1.35/1.75) 1.48 (1.23/1.75) 1.40 (1.12/1.65)
Mean Deposited PLTs (power laws) 366 321 416
Max Deposited PLTs (power laws) 1759 1512 2270
Mean Deposited PLTs Normal Dist. 246 174 287
Mean Deposited PLTs Exponential Dist. 250 175 290
In a second step, we used the fitted distributions as generative mechanisms for simulating random walks and the
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transport of PLTs in the impact-R device. Table 1 presents the amount of deposited PLTs (the ones that cross the
bottom wall) after running the stochastic simulations for 20 s of physical time, with L = 820 µm. Chopard et al.
[4] report that 3125 AP have disappeared from the bulk during these 20 s, with an initial concentration of 4808 AP
per micro-litre.
Given that the phenomenon is symmetric along the y-axis (cross-checked with the DNS), and due to the developed
cell free layer close to the walls (trapping the crossing PLTs), we expect at least 1500 platelets out of 4808 (1500 ∼
3125/2) to cross the bottom wall of the system.
Table 1 shows that this expected number of deposited platelets is compatible with the proposed fat-tailed velocity
distribution, without the need to invoke special drift terms or a rheological potential. The table also presents the
amount of deposited PLTs when forcing a Gaussian or exponential fit on the velocity distributions. Clearly, the
deposition values are way too small to describe the deposition rates observed in the in-vitro experiments. Therefore,
the use of standard diffusive models heavily underestimates the deposition rate, compared to the Le´vy flights that
produce a 2 to 10 times higher amount of deposited PLTs.
As shown in Fig. 4, it is also interesting to note that as opposed to the MSD which diverges with the system size,
the exponent α keeps a consistent value when varying L from 50 µm to 500 µm (scale-invariance of power laws, i.e.
the phenomena are expected to occur without a characteristic size or scale).
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Figure 4: Mean power law exponents per cellular blood flow simulation. The power laws are independent of the
system size (no diverging behaviour as with the moments of the velocity distribution). Any variation is due to the
different parameters per simulation (shapes, sizes, repulsive forces). The inset shows a few simulation snapshots
from systems of size 50 & 100 µm along the wall-bounded direction y.
4 Conclusions
Combining the power law fitting on the tails with the normality tests that fail in all the experiments, the diverging
moments of the velocity distribution, the very high kurtosis, and the good agreement with the impact-R deposition
data, we give convergent evidences that PLTs do not follow a Gaussian random walk, but rather Le´vy Flights. The
standard diffusion equation does not apply to describe PLTs transport. Fractional differential equations might be
needed to account for such an anomalous diffusion processes at the macroscopic scale.
As mentioned by Kumar and Graham [13], no clear and systematic mechanistic explanation was yet proposed for the
segregation and margination phenomena of platelets. In particular, no simplified mathematical description (such
10
as a set of transport equations or a simple stochastic process model) has emerged that captures the phenomena. In
this study, we prove that PLT velocities, more specifically the tail of their distribution, can be described by power
laws (P (v) ∼ v−α−1) with exponent α ≤ 2. We found no evidence of normally distributed PLT velocities, and thus
PLTs cannot possibly exhibit standard diffusion, which is the norm when describing PLT transport.
The new stochastic process model that we introduce does not need additional terms to describe margination, as is
the case in other studies [12, 5, 10]. A striking observation is that while our results are compatible with the stan-
dard models (diffusion extracted from MSD/variance/second central moment), a further investigation (statistical
analysis) reveals the anomalous behaviour of PLT transport. This can be explained from the fact that the more
fat-tailed a distribution, the more statistical information lies in the tail, and the moments (on which standard dif-
fusive models are built upon) become uninformative and unreliable. The majority of the numerical research in this
field is limited to case studies that deal with too few blood cells in the computational domain, and this is due to the
high computational cost of the simulations. Our highly scalable numerical framework allows us to investigate cases
with dimensions approaching the ones of the in-vitro experiment. We would like to emphasise that the ability to
study sizes of clinical relevance (at least resolving the direction of interest), allowed us to observe the idiosyncratic
behaviour of PLT transportation, and to capture the anomalous characteristics that manifest in setups of larger
sizes.
In addition to proposing a disruptive view of PLT transport physics in blood, our results have a concrete impact
on the design of new and efficient platelet function tests. Those can be a vital part for the detection of car-
dio/cerebrovascular diseases in clinical practice. Nowadays, there exist numerous platelet function tests for the
diagnosis of disorders or the monitoring of anti-platelet therapies, but with limited prognostic capacity in clinical
practice, due to contradicting results. As several studies show [29, 30, 31], there is a problem interpreting the
results and mapping them to patient risk and disease. We strongly believe that the emerging stochastic models
from the present analysis will offer a paradigm shift for developing the next generation tests, as the understanding
of PLT transport is inextricably associated with the success of platelet function testing. A first step in this direction
was proposed by Dutta et al. [32], a study in which clinically important properties, such as platelet adhesion and
aggregation rates, can only be correctly inferred provided that PLT transport can be correctly described.
Source Code
The source code for the statistical analysis is available in GitHub: https://github.com/kotsaloscv/PLTs-FatTails. The
tools for performing the cellular blood flow simulations, as presented in Kotsalos et al. [19, 20], are available as part of
Palabos open-source library (npFEM specialised module): https://palabos.unige.ch.
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Supplementary Material: Statistical Analysis (Graphical Explanation)
For every cellular blood flow simulation, we produce from the sampled output the histogram of platelet velocities
(velocities along the wall-bounded direction for channel flow, and radial velocities for tubular flow). Our goal is
to fit a model on this histogram and use it for simulating random walks. Below some lower bound (xmin), the
original data can be sufficiently described by the empirical distribution function (histogram), but above xmin, due
to the fractionate information that we get from the tail, we need to apply more sophisticated statistical models.
Since we are particularly interested on investigating the power law hypothesis, we fit a family of distributions that
asymptotically exhibit power law behaviour [18], e.g. Pareto, half-Cauchy, Le´vy, Dagum, Singh–Maddala, Log-
logistic, and inverted Weibull. Every distribution is fitted separately on the data (just at the tail), and therefore
the lower bound and power law exponent α vary per distribution (see figure below). The distributions with α ≤ 2
are characterised as fat-tailed or power laws, and their exponents (presented as mean, minimum & maximum per
DNS) describe the fatness of the tail, i.e. the lower the exponents the higher the tail events (large PLT velocities).
This analysis is performed for every cellular blood flow simulation, and the resulting power law exponents are
grouped/presented per PLT type (activated, non activated, and with/without repulsive forces).
xmin: optimal & relaxed (sub-optimal but larger sample size)
Empirical Distribution Function 
(EDF) - histogram
Tail distributions (power laws):
➢ Pareto
➢ Half-Cauchy
➢ Lévy
➢ Burr
➢ Fisk
➢ Fréchet
Different pair (xmin, α) per distribution
Try all x and choose the one that gives the best fit at the tail (KS-test): per distribution
x: PLT velocity
f   ̴ x-α-1, x → ∞
Asymptotic 
behavior
Statistical analysis per direct numerical simulation. Per investigated distribution, we define xmin
with the optimisation process as described in Methods, and α through the MLE method.
To generate data for the random walks, the DNS sampled output (per simulation) is split into the body and the
tail (see figure above). Regarding the body, we use the empirical distribution function (ECDF) for generating new
velocities. For the generated velocities that are above the xmin (varies per fitted distribution), we use the fitted
distributions to re-generate velocities belonging to the tail. For the new data to be as close as possible to the
original (from DNS), the fitted distributions should pass the goodness-of-fit and LLR tests. Assuming a plausible
distribution for the tail, it may be the case that the tail sample size is small (n ≈ 100). Fitting on samples of
small sizes should be treated with caution, because power laws may appear to be a good fit even when the data are
drawn from a non-power law distribution. An additional step to strengthen our confidence on power law behaviour
is to relax the xmin threshold, i.e. reduce the lower bound and thus increase the sample size on which to fit. For
this relaxed version, we need to perform an additional goodness-of-fit test [22]. For this test, we use as metric the
Kuiper’s statistic, which is a variation of the Kolmogorov-Smirnov, but more sensitive on capturing differences at
the tails. In short, we generate data from the ECDF, then synthetic data with the optimal xmin, and we compare
the two data sets using the Kuiper’s test, from which we get the statistic. Following, we generate another set
of synthetic data with the relaxed xmin, and we compare it with the data from the ECDF, extracting another
statistic. If the last statistic is smaller than the one of the first comparison, then the relaxed model is a valid
alternative. By repeating this process more than a thousand times [22], we get a p-value coming from the fraction
of valid/accepted relaxed models to the overall repetitions. Keep in mind, that the relaxed tail gives an additional
fitting for consideration, thus for each distribution we have the optimal and relaxed fittings. Therefore, per DNS
and per fitted distribution, we construct a generative mechanism that “feeds” the random walk models.
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Supplementary Material: Power Law Distributions
The probability densities presented here are in the “standardised” form, i.e. the location parameter is zero and the
scale parameter is one. However, the analysis is not affected by this “standardised” form, since these parameters
are only for shifting and scaling, respectively, the investigated distributions. The power law exponent α is given
by the asymptotic analysis of the distributions (probability density function-pdf), which decay like f ∼ x−α−1.
The presentation of the pdf with −1 in the exponent is deliberate, since the survival function (F¯ = Pr(X > x),
complementary cumulative distribution function) decays like F¯ ∼ x−α.
Pareto
The probability density function for Pareto is: f(x, b) = b
xb+1
for x ≥ 1, b > 0. For x → ∞, f(x, b) ∼ x−b−1. The
variance is ∞ for b ≤ 2 and the mean is ∞ for b ≤ 1. The power law exponent is b.
Half-Cauchy
The probability density function for half-Cauchy is: f(x) = 2pi(1+x2) for x ≥ 0. For x→∞, f(x) ∼ x−2. The mean
and variance are undefined. The power law exponent is fixed to 1.
Le´vy
The probability density function for Le´vy is: f(x) = 1√
2pix3
exp
(− 12x) for x ≥ 0. For x → ∞, f(x) ∼ x−1.5. Both
the mean and the variance are ∞. The power law exponent is fixed to 0.5.
Dagum (or Burr Type III)
The probability density function for Dagum is: f(x, c, d) = cdx−c−1/(1 + x−c)d+1 for x ≥ 0 and c, d > 0. For
x → ∞, f(x, c, d) ∼ x−c−1. The mean is undefined for c ≤ 1, and the variance is undefined for c ≤ 2. The power
law exponent is c.
Singh–Maddala (or Burr Type XII)
The probability density function for Singh–Maddala is: f(x, c, d) = cdxc−1/(1 + xc)d+1 for x ≥ 0 and c, d > 0. For
x → ∞, f(x, c, d) ∼ xc−1/xcd+c ∼ x−cd−1. The mean is undefined for cd ≤ 1, and the variance is undefined for
cd ≤ 2. The power law exponent is cd.
Log-logistic (or Fisk)
The probability density function for Log-logistic is: f(x, c) = cx−c−1(1 + x−c)−2 for x ≥ 0, c > 0. For x → ∞,
f(x, c) ∼ x−c−1. The mean is undefined for c ≤ 1, and the variance is undefined for c ≤ 2. The power law exponent
is c.
Inverted Weibull (or Fre´chet)
The probability density function for inverted Weibull is: f(x, c) = cx−c−1exp(−x−c) for x > 0, c > 0. For x→∞,
f(x, c) ∼ x−c−1. The mean is undefined for c ≤ 1, and the variance is undefined for c ≤ 2. The power law exponent
is c.
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Supplementary Material: Summary of DNS and Statistical Analysis
PLT : Activated/Non-Activated platelets, rep: no repulsive forces at 20 (weight of collision potential - DNS related), exp: ei-
ther scaled impact-R (box) or tube, dir : system size along the wall-bounded direction/diameter [µm], Ht : hematocrit [%], SR: Shear
Rate [s−1], num RBCs/PLTs: number of RBCs/PLTs in DNS, D (DNS): Diffusion Coefficient - MSD of DNS [m2/s], D (Gaussian):
Diffusion Coefficient - Random Walk (Gaussian fitted on DNS) [m2/s], fat-tails: number of accepted power laws (considering only the
ones with α ≤ 2) for both optimal and relaxed tail fitting, min sample size: minimum sample size of one of the accepted power laws,
avg sample size: average sample size considering all accepted power laws, avg exp: average power law exponent considering all accepted
power laws, max depo: deposited PLTs (after 20s physical time [4]) using the random walks (Impact-R at full scale) corresponding to
the min exp. Simulations that seem to repeat are with/without the Particle In Kernel (PIK) technique [20] (validating its consistency).
PLT rep exp dir Ht SR
num
RBCs
num
PLTs
D
(DNS)
D
(Gaussian)
excess
kurtosis
fat-tails
min
sample
size
avg
sample
size
avg
exp
min
exp
max
exp
max
depo
AP 200 box 500 35 100 4765 953 3.00E-10 1.12E-10 23.3 2 640 822 1.522 1.35 1.70 367
AP 200 box 500 35 100 4765 953 3.11E-10 1.01E-10 31.4 3 362 619 1.302 1.00 1.63 384
AP 200 box 50 35 100 476 95 1.40E-10 1.27E-10 17.5 4 181 772 1.319 1.00 1.59 640
AP 200 box 50 20 100 272 54 1.54E-10 4.87E-11 5.4 3 104 540 1.314 1.00 1.49 413
AP 200 box 100 35 100 953 190 2.87E-10 1.77E-10 26.8 2 508 3081 1.325 1.30 1.35 879
AP 200 box 50 35 100 476 95 1.71E-10 1.28E-10 39.2 8 102 1194 1.359 1.00 1.62 2270
AP 200 box 50 20 100 272 54 1.11E-10 5.65E-11 4.6 3 101 880 1.735 1.50 1.86 375
AP 200 tube 52 35 200 374 74 1.06E-10 1.07E-10 20.0 6 136 402 1.418 1.00 1.96 4659
AP 200 tube 52 35 200 374 74 7.97E-11 1.67E-10 21.8 6 144 530 1.345 1.00 1.71 2509
AP 100 box 100 35 100 953 190 1.27E-10 5.33E-11 7.3 3 271 464 1.338 1.00 1.76 325
AP 100 box 500 35 100 4765 953 1.09E-10 3.92E-11 41.0 6 178 513 1.490 1.00 1.97 743
AP 100 box 50 35 100 476 95 7.32E-11 4.87E-11 5.1 3 108 919 1.368 1.00 1.61 270
AP 100 box 50 20 100 272 54 8.94E-11 2.96E-11 2.6 6 102 505 1.489 1.00 1.91 1315
AP 100 box 100 35 100 953 190 1.89E-10 6.35E-11 46.0 5 301 1633 1.282 1.00 1.59 565
AP 100 box 100 35 100 953 190 1.13E-10 5.77E-11 14.2 5 283 740 1.546 1.00 1.95 731
AP 100 box 250 35 100 2382 476 4.12E-10 1.60E-10 84.5 1 184 184 1.454 1.45 1.45 398
AP 100 box 50 35 100 476 95 1.08E-10 5.56E-11 9.0 2 108 159 1.473 1.39 1.56 237
AP 20 box 50 35 100 476 47 6.06E-11 3.01E-10 125.8 4 2155 2580 0.765 0.72 0.86 4782
AP 20 box 50 35 100 476 95 5.81E-11 1.86E-11 1.6 2 141 1155 1.615 1.59 1.64 210
AP 20 box 50 35 100 476 95 5.81E-11 2.57E-11 3.8 5 130 838 1.338 1.00 1.59 215
AP 20 box 50 35 100 476 95 6.17E-11 2.61E-11 1.2 4 120 1176 1.454 1.00 1.64 204
AP 20 box 50 35 100 476 95 7.20E-11 5.14E-11 44.7 7 457 1860 1.336 1.00 1.91 1512
AP 20 box 50 35 100 476 95 7.91E-11 4.00E-11 15.2 4 107 4085 1.646 1.40 1.92 365
AP 20 box 50 20 100 272 54 8.78E-11 1.35E-11 1.8 0
AP 20 box 100 35 100 953 190 8.99E-11 6.47E-11 155.9 5 109 4567 1.588 1.30 1.94 573
AP 20 box 250 35 100 2382 476 1.29E-10 6.15E-11 111.5 3 166 8197 1.580 1.51 1.70 345
AP 20 box 500 35 100 4765 953 5.92E-11 1.91E-11 107.3 3 229 10127 1.527 1.28 1.75 223
AP 20 box 50 35 100 476 95 8.17E-11 3.34E-11 39.1 5 387 1197 1.254 1.00 1.62 1312
AP 20 box 50 20 100 272 54 4.11E-11 1.69E-11 1.5 0
AP 20 tube 52 35 200 374 74 6.11E-11 2.74E-11 4.5 4 102 544 1.358 1.00 1.73 1093
NAP 20 box 50 35 100 476 95 1.18E-10 8.74E-11 42.3 2 7090 7933 1.736 1.72 1.75 363
NAP 20 box 100 35 100 953 190 9.82E-11 6.22E-11 70.8 4 756 4044 1.472 1.23 1.77 558
NAP 20 box 250 35 100 2382 476 1.37E-10 6.36E-11 295.1 3 1731 8573 1.568 1.29 1.84 375
NAP 20 box 500 35 100 4765 953 1.09E-10 5.05E-11 862.8 1 3867 3867 1.177 1.18 1.18 464
NAP 20 box 50 35 100 476 95 5.70E-11 2.72E-11 4.7 4 110 1216 1.480 1.00 1.76 279
NAP 20 box 50 35 100 476 95 1.12E-10 4.67E-11 16.1 2 1030 2223 1.708 1.59 1.83 256
NAP 20 box 50 35 100 370 74 3.06E-10 1.46E-10 21.0 0
NAP 20 box 50 35 400 476 95 1.72E-10 1.50E-10 28.8 8 454 1118 1.490 1.00 1.98 2180
NAP 20 box 50 35 400 476 95 1.61E-10 2.07E-10 15.2 3 115 2879 1.552 1.30 1.85 1342
NAP 20 box 50 35 400 370 74 2.73E-10 2.89E-10 10.5 2 1180 1567 1.753 1.66 1.85 839
NAP 20 box 50 35 100 476 95 7.93E-11 7.36E-11 28.3 8 102 3119 1.467 1.00 1.94 1759
NAP 20 box 50 35 100 476 95 1.02E-10 4.89E-11 21.9 4 498 2012 1.562 1.28 1.88 432
NAP 20 box 50 35 100 370 74 1.46E-10 7.13E-11 14.0 2 869 1901 1.719 1.68 1.76 393
NAP 20 box 50 35 400 476 95 1.62E-10 1.73E-10 9.7 0
NAP 20 box 50 35 400 476 95 1.44E-10 1.09E-10 2.7 3 189 1145 1.333 1.00 1.52 536
NAP 20 box 50 35 400 370 74 2.06E-10 2.47E-10 10.3 2 776 1308 1.757 1.69 1.83 619
NAP 20 box 100 35 100 953 190 1.91E-10 9.95E-11 36.1 2 9172 9529 1.516 1.50 1.53 471
NAP 20 box 500 35 100 4765 953 1.44E-10 5.95E-11 65.6 2 110 9762 1.820 1.72 1.92 301
NAP 20 box 50 35 100 476 95 1.25E-10 4.84E-11 14.7 6 105 1707 1.597 1.37 1.88 513
NAP 20 tube 52 35 200 374 74 5.31E-11 3.09E-11 5.3 3 108 474 1.770 1.55 1.91 268
NAP 20 tube 52 35 200 374 74 4.39E-11 4.48E-11 7.1 7 123 298 1.423 1.00 1.91 4797
NAP 20 box 50 35 100 476 95 1.36E-10 1.11E-10 34.1 5 1044 2692 1.546 1.22 1.88 718
NAP 20 box 50 35 100 476 95 1.06E-10 5.32E-11 3.1 4 113 1053 1.438 1.00 1.73 296
NAP 20 box 50 35 100 476 95 6.32E-11 4.07E-11 12.9 4 147 738 1.313 1.00 1.47 360
NAP 20 box 50 35 100 476 95 7.55E-11 3.65E-11 20.0 5 107 1049 1.325 1.00 1.73 1386
NAP 20 box 50 35 100 476 95 1.26E-10 1.17E-10 38.2 2 11308 12913 1.879 1.84 1.92 421
NAP 20 box 50 35 100 476 95 1.18E-10 9.06E-11 42.3 2 7090 7933 1.736 1.72 1.75 378
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